• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA 结构特异性核酸酶 DENND4C 是一种新型的上皮性卵巢癌血清标志物,通过下调 miR-200b/c 发挥肿瘤抑制作用。

circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.

机构信息

Department of Gynecology, The Fifth People's Hospital of Jinan, Jinan, China.

Department of Obstetrics, The Fifth People's Hospital of Jinan, Jinan, China.

出版信息

Ann Med. 2023 Dec;55(1):908-919. doi: 10.1080/07853890.2023.2185289.

DOI:10.1080/07853890.2023.2185289
PMID:36896567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10795628/
Abstract

RESEARCH OBJECTIVE

To explore the diagnostic value of circ-DENN domain containing 4 C (circDENND4C) in epithelial ovarian cancer (EOC) and the corresponding mechanism.

METHODS

We determined the expression of circDENND4C and miR-200b/c in tissues and serum specimens as well as EOC cell lines using qRT-PCR. Basic clinical data, and serum HE4 and CAl25 levels were acquired from patients' clinical records. Expression-related correlations and the diagnostic value of serum circDENND4C in EOC were also estimated. CCK-8 and flow cytometry were performed to detect the effect of circDENND4C on cell proliferation and apoptosis.

RESULTS

circDENND4C level was lowest while miR-200b/c was highest in EOC tissues, followed by benign and normal tissues. Similarly, serum circDENND4C was lowest while miR-200b/c was highest in EOC patients. Moreover, serum circDENND4C was lower in patients with benign ovarian tumors than in healthy women, while miR-200b/c expression was higher. circDENND4C was negatively associated with miR-200b/c in EOC tissues and serum specimens, and serum circDENND4C was also negatively correlated with serum HE4 and CAl25 in EOC patients. circDENND4C expression in both tissue and serum was negatively related to FIGO and TNM stage, and tumor size in EOC. Serum circDENND4C could distinguish healthy persons from patients with benign ovarian tumors and EOC, and they showed a higher specificity and accuracy than serum CA125 or HE4 in EOC diagnosis. circDENND4C upregulation significantly suppressed EOC cell proliferation and facilitated apoptosis by downregulating miR-200b/c .

CONCLUSIONS

Summarily, circDENND4C acts as a tumor inhibitor by downregulating miR-200b/c in EOC and could be a possible tumor marker for EOC diagnosis.KEY MESSAGEScircDENND4C expression was lowest while miR-200b/c was highest in EOC tissues or serums, followed by benign and normal tissues or serums.circDENND4C was involved in malignant progression of EOC, concretely, overexpression of circDENND4C suppressed EOC cell proliferation and stimulated apoptosis via downregulating miR-200b/c, and circDENND4C expression in both tissue and serum was closely related to FIGO and TNM stages and tumor size in EOC.Serum circDENND4C showed a higher specificity and accuracy than serum CA125 or HE4 in EOC diagnosis.HIGHLIGHTScircDENND4C expression was lowest while miR-200b/c was highest in EOC tissues, followed by benign and normal tissues.Serum circDENND4C was lowest while miR-200b/c was highest in EOC patients, followed by benign patients and healthy women.Overexpression of circDENND4C suppresses EOC cell proliferation and stimulates apoptosis via downregulating miR-200b/c.circDENND4C expression in both tissue and serum was closely related to FIGO and TNM stage and tumor size in EOC.Serum circDENND4C showed a higher specificity and accuracy than serum CA125 or HE4 in EOC diagnosis.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/67481ffdf8fd/IANN_A_2185289_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/8d46f6624bc4/IANN_A_2185289_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/079de74303e8/IANN_A_2185289_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/a112601cedde/IANN_A_2185289_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/682a85b3036f/IANN_A_2185289_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/7dcaad6ca268/IANN_A_2185289_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/67481ffdf8fd/IANN_A_2185289_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/8d46f6624bc4/IANN_A_2185289_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/079de74303e8/IANN_A_2185289_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/a112601cedde/IANN_A_2185289_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/682a85b3036f/IANN_A_2185289_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/7dcaad6ca268/IANN_A_2185289_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc2/10795628/67481ffdf8fd/IANN_A_2185289_F0006_C.jpg
摘要

研究目的

探讨环状 DENN 结构域包含 4C(circDENND4C)在卵巢上皮性癌(EOC)中的诊断价值及其相关机制。

方法

采用 qRT-PCR 检测组织和血清标本以及 EOC 细胞系中 circDENND4C 和 miR-200b/c 的表达。从患者的临床记录中获取基本临床数据以及血清 HE4 和 CA125 水平。还评估了血清 circDENND4C 在 EOC 中的表达相关性和诊断价值。通过 CCK-8 和流式细胞术检测 circDENND4C 对细胞增殖和凋亡的影响。

结果

EOC 组织中 circDENND4C 水平最低,miR-200b/c 水平最高,良性和正常组织次之。同样,EOC 患者血清 circDENND4C 最低,miR-200b/c 最高。此外,与健康女性相比,良性卵巢肿瘤患者的血清 circDENND4C 水平较低,而 miR-200b/c 的表达水平较高。circDENND4C 在 EOC 组织和血清标本中与 miR-200b/c 呈负相关,并且 EOC 患者的血清 circDENND4C 也与血清 HE4 和 CA125 呈负相关。circDENND4C 在组织和血清中的表达与 EOC 的 FIGO 和 TNM 分期以及肿瘤大小呈负相关。血清 circDENND4C 可将健康人与良性卵巢肿瘤和 EOC 患者区分开来,与血清 CA125 或 HE4 相比,其在 EOC 诊断中的特异性和准确性更高。circDENND4C 的上调通过下调 miR-200b/c 显著抑制 EOC 细胞增殖并促进细胞凋亡。

结论

综上所述,circDENND4C 通过下调 miR-200b/c 在 EOC 中发挥肿瘤抑制作用,可能是 EOC 诊断的潜在肿瘤标志物。

关键信息

  • 在 EOC 组织或血清中,circDENND4C 表达最低,miR-200b/c 表达最高,良性和正常组织或血清中次之。

  • circDENND4C 参与 EOC 的恶性进展,具体而言,circDENND4C 的过表达通过下调 miR-200b/c 抑制 EOC 细胞增殖并刺激细胞凋亡,组织和血清中的 circDENND4C 表达与 EOC 的 FIGO 和 TNM 分期以及肿瘤大小密切相关。

  • 与血清 CA125 或 HE4 相比,血清 circDENND4C 在 EOC 诊断中的特异性和准确性更高。

相似文献

1
circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.环状 RNA 结构特异性核酸酶 DENND4C 是一种新型的上皮性卵巢癌血清标志物,通过下调 miR-200b/c 发挥肿瘤抑制作用。
Ann Med. 2023 Dec;55(1):908-919. doi: 10.1080/07853890.2023.2185289.
2
Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.血清miR-193a-5p、HE4和CA125诊断模型提高上皮性卵巢癌的诊断效能。
Pathol Oncol Res. 2018 Oct;24(4):739-744. doi: 10.1007/s12253-018-0392-x. Epub 2018 Mar 8.
3
Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.上皮性卵巢癌患者循环中的游离miR-373、miR-200a、miR-200b和miR-200c
Adv Exp Med Biol. 2016;924:3-8. doi: 10.1007/978-3-319-42044-8_1.
4
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.循环外泌体miR-373、miR-200a、miR-200b和miR-200c在上皮性卵巢癌患者中的诊断和预后相关性
Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850.
5
Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.组织CA125和HE4基因表达水平在鉴别盆腔良恶性肿块方面具有更高的准确性。
Asian Pac J Cancer Prev. 2016;17(1):323-33. doi: 10.7314/apjcp.2016.17.1.323.
6
Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.HE4 和 CA125 标志物在 I 型和 II 型上皮性卵巢癌中的诊断性能。
Gynecol Oncol. 2013 Oct;131(1):52-8. doi: 10.1016/j.ygyno.2013.07.094. Epub 2013 Jul 25.
7
The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.sEGFR、CA125 和 HE4 联合检测对上皮性卵巢癌诊断的临床价值。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):604-610. doi: 10.26355/eurrev_202001_20036.
8
High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.高表达的 microRNA-200a/b 可作为上皮性卵巢癌潜在的诊断和预后生物标志物。
Dis Markers. 2022 Mar 25;2022:2751696. doi: 10.1155/2022/2751696. eCollection 2022.
9
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.血清人附睾蛋白 4 和卵巢恶性肿瘤算法作为上皮性卵巢癌管理的新的诊断和预后工具。
Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2496-506. doi: 10.1158/1055-9965.EPI-11-0635. Epub 2011 Oct 25.
10
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.上皮性卵巢癌患者卵巢恶性肿瘤风险的诊断措施比较:一项荟萃分析。
Sci Rep. 2021 Aug 27;11(1):17308. doi: 10.1038/s41598-021-96552-9.

引用本文的文献

1
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.靶向人类癌症中的调控性非编码RNA:临床试验的现状
Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471.
2
circDENND4C serves as a sponge for miR-200b to drive non-small cell lung cancer advancement by regulating MMP-9 expression.环状DENND4C作为miR-200b的海绵,通过调节MMP-9表达来驱动非小细胞肺癌进展。
Front Oncol. 2025 Feb 17;15:1441384. doi: 10.3389/fonc.2025.1441384. eCollection 2025.
3
Serum hsa_circ_0007534 as a diagnostic biomarker for ovarian cancer.

本文引用的文献

1
Calcineurin Gamma Catalytic Subunit PPP3CC Inhibition by miR-200c-3p Affects Apoptosis in Epithelial Ovarian Cancer.miR-200c-3p 通过抑制钙调神经磷酸酶 γ 催化亚基 PPP3CC 影响上皮性卵巢癌细胞凋亡。
Genes (Basel). 2021 Sep 10;12(9):1400. doi: 10.3390/genes12091400.
2
MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.miR-200b-5p 通过靶向 ATAD2 并调节 PI3K/AKT 信号通路抑制卵巢癌细胞的增殖。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9860-9868. doi: 10.26355/eurrev_202010_23196.
3
MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
血清hsa_circ_0007534作为卵巢癌的诊断生物标志物。
Am J Transl Res. 2024 Oct 15;16(10):5630-5636. doi: 10.62347/KHAK2629. eCollection 2024.
4
Ovarian cancer: Diagnosis and treatment strategies (Review).卵巢癌:诊断与治疗策略(综述)
Oncol Lett. 2024 Jul 18;28(3):441. doi: 10.3892/ol.2024.14574. eCollection 2024 Sep.
MicroRNA-195 通过抑制 CDC42/CCND1 通路抑制上皮性卵巢癌中的细胞增殖、迁移和侵袭。
Int J Mol Med. 2020 Nov;46(5):1862-1872. doi: 10.3892/ijmm.2020.4716. Epub 2020 Aug 31.
4
Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts.miR-200 家族在肿瘤组织、血浆和上皮性卵巢癌患者尿液中的表达与良性肿瘤对照的比较。
BMC Res Notes. 2020 Jul 1;13(1):311. doi: 10.1186/s13104-020-05155-6.
5
miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5.miR-200b/200a/429簇通过靶向ING5促进卵巢癌发展。
J Oncol. 2020 Apr 22;2020:3404059. doi: 10.1155/2020/3404059. eCollection 2020.
6
miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16.miR-873-5p通过调控CXCL16抑制甲状腺乳头状癌的细胞迁移和侵袭。
Onco Targets Ther. 2020 Feb 4;13:1037-1046. doi: 10.2147/OTT.S213168. eCollection 2020.
7
RNA-Seq profiling of circular RNAs in human small cell lung cancer.环状 RNA 在人小细胞肺癌中的 RNA-Seq 分析。
Epigenomics. 2020 Apr;12(8):685-700. doi: 10.2217/epi-2019-0382. Epub 2020 Feb 21.
8
Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22.Circ_0039569通过调控miR-34a-5p/CCL22促进肾细胞癌的生长和转移。
Am J Transl Res. 2019 Aug 15;11(8):4935-4945. eCollection 2019.
9
Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia.敲低 circDENND4C 通过上调低氧下乳腺癌中的 miR-200b/c 抑制糖酵解、迁移和侵袭。
J Exp Clin Cancer Res. 2019 Sep 5;38(1):388. doi: 10.1186/s13046-019-1398-2.
10
Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.hsa_circ_0007534 的下调通过调节 miR-498/BMI-1 信号通路限制宫颈癌的增殖和侵袭。
Life Sci. 2019 Oct 15;235:116785. doi: 10.1016/j.lfs.2019.116785. Epub 2019 Aug 21.